Home | Sitemap | Submit Content | Contact Us   
imageHome : Latest News : Nivestim(TM), a New Biosimilar Filgrastim, is Approved in Europe for the Prevention of Febrile... - Forbes

Nivestim(TM), a New Biosimilar Filgrastim, is Approved in Europe for the Prevention of Febrile... - Forbes

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service63 times read : Adjust font size: Decrease font Enlarge font
image

LEAMINGTON SPA, United Kingdom, June 10 /PRNewswire-FirstCall/ -- Hospira announced today that the EC has approved Nivestim(TM) (filgrastim) for the prevention of FN, the most serious haematological toxicity that occurs ...

Read this article...



Post your comment comment Comments (0 posted)

copyright